Published in TB and Outbreaks Week, October 16th, 2001
"This alliance represents an opportunity to use Molsoft's molecular modeling software and Plexus Vaccine's structure-based vaccine design to develop epitope-specific vaccines that generate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.